Early research (Phase 1)Study completedNCT00563316What this trial is testingEffect of Panitumumab on the Pharmacokinetics of IrinotecanWho this might be right forMetastatic Colorectal Cancer Amgen 28
Large-scale testing (Phase 3)UnknownNCT02339116What this trial is testingFolfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRCWho this might be right forMetastatic Colorectal Cancer Gruppo Oncologico del Nord-Ovest 654
Testing effectiveness (Phase 2)UnknownNCT05035381What this trial is testingPD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal CancerWho this might be right forMSI-H Advanced Colorectal Cancer Tianjin Medical University Cancer Institute and Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06885034What this trial is testingTest the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)Who this might be right forGastrointestinal Neoplasms GlaxoSmithKline 451
Large-scale testing (Phase 3)Looking for participantsNCT06509126What this trial is testingIntermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerWho this might be right forColorectal Cancer Stage IV National Cancer Institute, Naples 500
Testing effectiveness (Phase 2)UnknownNCT05167448What this trial is testingES104 in Patients With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Elpiscience (Suzhou) Biopharma, Ltd. 58
Not applicableUnknownNCT01048216What this trial is testingPartial Liver Radiotherapy for Unresectable Liver MetastasesWho this might be right forMetastatic Colorectal Liver Cancer Royal Marsden NHS Foundation Trust 18
Testing effectiveness (Phase 2)WithdrawnNCT01293942What this trial is testingIXO+A in mCRC With Liver-only MetastasesWho this might be right forMetastatic Colorectal Cancer Ottawa Hospital Research Institute
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)UnknownNCT05289076What this trial is testingEvaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo ModelWho this might be right forColorectal Cancer MetastaticTumour MetastasisChemotherapy Effect+1 more University Hospital, Linkoeping 40
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Looking for participantsNCT06218810What this trial is testingCadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal CancerMicrosatellite Stable Colorectal CarcinomaRAS Mutation+1 more Fudan University 53
Large-scale testing (Phase 3)UnknownNCT03783559What this trial is testingTACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)Who this might be right forColorectal Adenocarcinoma Metastatic to the Liver Fudan University 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446387What this trial is testingA Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal CancerWho this might be right forMetastatic Colorectal Cancer (CRC) Jiangsu Cancer Institute & Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Early research (Phase 1)Study completedNCT01787500What this trial is testingVemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryWho this might be right forBRAF NP_004324.2:p.V600XKRAS wt AlleleMetastatic Malignant Solid Neoplasm+4 more M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)WithdrawnNCT04430985What this trial is testingFOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Dorte Nielsen
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Early research (Phase 1)Active Not RecruitingNCT05838768What this trial is testingStudy of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.Who this might be right forMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Novartis Pharmaceuticals 123
Testing effectiveness (Phase 2)UnknownNCT04866108What this trial is testingA Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous ChemotherapyWho this might be right forUnresectable Metastatic Colorectal Cancer Beijing Friendship Hospital 49